Identification of peptide mimotopes of gp96 using single-chain antibody library

Cell Stress and Chaperones

Volumn 16, Issue 2, 2011, Pages 225-234

  Shanmugam, Arulkumaran ^a   Suriano, Robert ^a   Goswami, Neha ^a   Chaudhuri, Devyani ^a   Ashok, Badithe T ^a   Rajoria, Shilpi ^a   George, Andrea L ^a   Mittelman, Abraham ^a   Tiwari, Raj K ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

gp96; Heat shock protein; Mimotope; Phage display; Prostate cancer

Indexed keywords

ALUMINUM SALT; CANCER VACCINE; FREUND ADJUVANT; GLYCOPROTEIN 36 ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 4; INTERLEUKIN 5; LIPOSOME; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROSTATE CANCER; RAT; SPLEEN CELL; TREATMENT RESPONSE;

ANIMALS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; PEPTIDE LIBRARY; PEPTIDES; PROSTATIC NEOPLASMS; RATS; SINGLE-CHAIN ANTIBODIES; VACCINES;

ANIMALIA; MUS;

EID: 79951676732     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-010-0234-6     Document Type: Article

References (43)

1. BT Ashok L David YG Chen VP Garikapaty B Chander D Kanduc A Mittelman RK Tiwari 2003 Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer Int J Mol Med 11 4 465 471 1:CAS:528:DC%2BD3sXis1yitLs%3D 12632099
2. Assikis VJ, Daliani D, Pagliaro L et al (2003) Phase II study of an autologous tumor derived heat shock protein-peptide complex vaccine (HSPPC-96) for patients with metastatic renal cell carcinoma (Mrcc). 2003 ASCO annual meeting proceedings, Chicago, USA (Abstract 1552)
3. F Belli A Testori L Rivoltini M Maio G Andreola MR Sertoli G Gallino A Piris A Cattelan I Lazzari M Carrabba G Scita C Santantonio L Pilla G Tragni C Lombardo F Arienti A Marchianò P Queirolo F Bertolini A Cova E Lamaj L Ascani R Camerini M Corsi N Cascinelli JJ Lewis P Srivastava G Parmiani 2002 Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings J Clin Oncol 20 20 4169 4180 1:CAS:528:DC%2BD38XnsFyqsbg%3D 10.1200/JCO.2002.09.134 12377960 (Pubitemid 35191019)
4. H Bendz SC Ruhland MJ Pandya O Hainzl S Riegelsberger C Braüchle MP Mayer J Buchner RD Issels E Noessner 2007 Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling J Biol Chem 282 43 31688 31702 1:CAS:528:DC%2BD2sXhtFykurfF 10.1074/jbc.M704129200 17684010 (Pubitemid 350044903)
5. RJ Binder JB Kelly 3rd RE Vatner PK Srivastava 2007 Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins J Immunol 179 11 7254 7261 1:CAS:528:DC%2BD2sXhtlajt77E 18025167
6. LL Bonnycastle JS Mehroke M Rashed X Gong JK Scott 1996 Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage J Mol Biol 258 5 747 762 1:CAS:528:DyaK28XjtFOgt74%3D 10.1006/jmbi.1996.0284 8637007 (Pubitemid 26150878)
7. SK Calderwood SS Mambula PJ Gray Jr 2007 Extracellular heat shock proteins in cell signaling and immunity Ann NY Acad Sci 1113 28 39 1:CAS:528:DC%2BD2sXhsVanurbP 10.1196/annals.1391.019 17978280
8. L Cohen C de Moor PA Parker RJ Amato 2002 Quality of life in patients with metastatic renal cell carcinoma participating in a phase I trial of an autologous tumor-derived vaccine Urol Oncol 7 3 119 124 1:CAS:528: DC%2BD38Xjtl2lsr0%3D 10.1016/S1078-1439(01)00182-X 12474545
9. AD Doody JT Kovalchin MA Mihalyo AT Hagymasi CG Drake AJ Adler 2004 Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function J Immunol 172 10 6087 6092 1:CAS:528:DC%2BD2cXjs1OjtbY%3D 15128793 (Pubitemid 38621211)
10. AL Fink 1999 Chaperone-mediated protein folding Physiol Rev 79 2 425 449 1:CAS:528:DyaK1MXivFektb4%3D 10221986 (Pubitemid 29210927)
11. R Gastpar C Gross L Rossbacher J Ellwart J Riegger G Multhoff 2004 The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells J Immunol 172 2 972 980 1:CAS:528:DC%2BD2cXnvVGn 14707070 (Pubitemid 38113756)
12. WJ Gullick 1994 Production of antisera to synthetic peptides Methods Mol Biol 32 389 399 1:CAS:528:DyaK2cXlslOjtLc%3D 7951738
13. B Guy 2007 The perfect mix: recent progress in adjuvant research Nat Rev Microbiol 5 7 505 517 1:CAS:528:DC%2BD2sXms1Skurc%3D 10.1038/nrmicro1681 17558426 (Pubitemid 46925379)
14. FU Hartl M Hayer-Hartl 2002 Molecular chaperones in the cytosol: from nascent chain to folded protein Science 295 5561 1852 1858 1:CAS:528: DC%2BD38XhvFClsL4%3D 10.1126/science.1068408 11884745 (Pubitemid 34214115)
15. A Hoos DL Levey JJ Lewis 2004 Autologous heat shock protein-peptide complexes for vaccination against cancer: from bench to bedside Dev Biol (Basel) 116 109 115 1:CAS:528:DC%2BD2cXpvFOhsbo%3D
16. S Janetzki D Palla V Rosenhauer H Lochs JJ Lewis PK Srivastava 2000 Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study Int J Cancer 88 2 232 238 1:CAS:528:DC%2BD3cXntlynur0%3D 10.1002/1097-0215(20001015)88:2<232::AID- IJC14>3.0.CO;2-8 11004674
17. CA Janeway Jr R Medzhitov 2002 Innate immune recognition Annu Rev Immunol 20 197 216 1:CAS:528:DC%2BD38XjtlWgt7Y%3D 10.1146/annurev.immunol.20.083001. 084359 11861602 (Pubitemid 34293424)
18. C Jolivet-Reynaud M Lésenéchal B O'Donnell L Becquart A Foussadier F Forge N Battail-Poirot X Lacoux W Carman M Jolivet 2001 Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies J Med Virol 65 2 241 249 1:CAS:528:DC%2BD3MXntVKnsro%3D 10.1002/jmv.2026 11536229 (Pubitemid 32816693)
19. C Jolivet-Reynaud A Adida S Michel G Deléage G Paranhos-Baccala V Gonin N Battail-Poirot X Lacoux D Rolland 2004 Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase J Med Virol 72 3 385 395 1:CAS:528:DC%2BD2cXhvVCjtLo%3D 10.1002/jmv.20002 14748062 (Pubitemid 38133979)
20. Z Li 1997 Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines Semin Immunol 9 5 315 322 1:CAS:528: DyaK2sXms12ru7g%3D 10.1006/smim.1997.0087 9327526 (Pubitemid 28077729)
21. Z Li A Menoret P Srivastava 2002 Roles of heat-shock proteins in antigen presentation and cross-presentation Curr Opin Immunol 14 1 45 51 1:CAS:528:DC%2BD38XktFGqtw%3D%3D 10.1016/S0952-7915(01)00297-7 11790532 (Pubitemid 34085106)
22. V Mazzaferro J Coppa MG Carrabba L Rivoltini M Schiavo E Regalia L Mariani T Camerini A Marchianò S Andreola R Camerini M Corsi JJ Lewis PK Srivastava G Parmiani 2003 Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer Clin Cancer Res 9 9 3235 3245 1:CAS:528:DC%2BD3sXotFCksL4%3D 12960108 (Pubitemid 37082717)
23. G Multhoff L Mizzen CC Winchester CM Milner S Wenk G Eissner HH Kampinga B Laumbacher J Johnson 1999 Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells Exp Hematol 27 11 1627 1636 1:CAS:528:DyaK1MXnvVehs7s%3D 10.1016/S0301-472X(99)00104-6 10560910 (Pubitemid 29526747)
24. A Nissim HR Hoogenboom IM Tomlinson G Flynn C Midgley D Lane G Winter 1994 Antibody fragments from a 'single pot' phage display library as immunochemical reagents EMBO J 13 3 692 698 1:CAS:528:DyaK2cXhvV2jtL0%3D 7508862 (Pubitemid 24050684)
25. Y Oki A Younes 2004 Heat shock protein-based cancer vaccines Expert Rev Vaccin 3 4 403 411 1:CAS:528:DC%2BD2cXlvVOkurY%3D 10.1586/14760584.3.4.403 (Pubitemid 39061705)
26. L Pilla R Patuzzo L Rivoltini M Maio E Pennacchioli E Lamaj A Maurichi S Massarut A Marchianò C Santantonio D Tosi F Arienti A Cova G Sovena A Piris D Nonaka I Bersani A Di Florio M Luigi PK Srivastava A Hoos M Santinami G Parmiani 2006 A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients Cancer Immunol Immunother 55 8 958 968 1:CAS:528:DC%2BD28XjvFGisb4%3D 10.1007/s00262-005-0084-8 16215718 (Pubitemid 43673585)
27. AG Pockley M Muthana SK Calderwood 2008 The dual immunoregulatory roles of stress proteins Trends Biochem Sci 33 2 71 79 1:CAS:528:DC%2BD1cXhvVWhtr4%3D 18182297
28. Richards J, Testoria A, Whitman E et al (2006) Autologous tumor-derived HSPPC-96 vs. physician's choice (PC) in a randomized phase III trial in stage IV melanoma. ASCO annual meeting proceedings, Atlanta, USA (2006) (Abstract 8002)
29. D SenGupta PJ Norris TJ Suscovich M Hassan-Zahraee HF Moffett A Trocha R Draenert PJ Goulder RJ Binder DL Levey BD Walker PK Srivastava C Brander 2004 Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II J Immunol 173 3 1987 1993 1:CAS:528:DC%2BD2cXlvVajtrk%3D 15265933 (Pubitemid 38971635)
30. T Sharav KH Wiesmüller P Walden 2007 Mimotope vaccines for cancer immunotherapy Vaccine 25 16 3032 3037 1:CAS:528:DC%2BD2sXjslSrs7w%3D 10.1016/j.vaccine.2007.01.033 17276556 (Pubitemid 46482734)
31. DJ Shedlock H Shen 2003 Requirement for CD4 T cell help in generating functional CD8 T cell memory Science 300 5617 337 339 1:CAS:528: DC%2BD3sXislyqtLc%3D 10.1126/science.1082305 12690201 (Pubitemid 36433726)
32. P Srivastava 2002 Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses Annu Rev Immunol 20 395 425 1:CAS:528:DC%2BD38XjtlWgtLo%3D 10.1146/annurev.immunol.20.100301.064801 11861608 (Pubitemid 34293430)
33. PK Srivastava AB Deleo LJ Old 1986 Tumor rejection antigens of chemically induced carcinomas of inbred mice Proc Natl Acad Sci USA 83 3407 3411 1:CAS:528:DyaL28XktVCktr0%3D 10.1073/pnas.83.10.3407 3458189 (Pubitemid 16043046)
34. PK Srivastava YT Chen LJ Old 1987 5-Structural analysis of genes encoding polymorphic antigens of chemically induced tumors Proc Natl Acad Sci USA 84 11 3807 3811 1:CAS:528:DyaL2sXktlChtr4%3D 10.1073/pnas.84.11.3807 2438686 (Pubitemid 17088368)
35. JC Sun MJ Bevan 2003 Defective CD8 T cell memory following acute infection without CD4 T cell help Science 300 5617 339 342 1:CAS:528: DC%2BD3sXislyqtb4%3D 10.1126/science.1083317 12690202 (Pubitemid 36433727)
36. R Suriano SK Ghosh BT Ashok A Mittelman Y Chen A Banerjee RK Tiwari 2005 Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention Cancer Res 65 6466 6475 1:CAS:528: DC%2BD2MXmt1egur8%3D 10.1158/0008-5472.CAN-04-4639 16024652 (Pubitemid 40994436)
37. R Suto PK Srivastava 1995 A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides Science 269 5230 1585 1588 1:CAS:528:DyaK2MXotVOgtrk%3D 10.1126/science.7545313 7545313
38. A Testori J Richards E Whitman GB Mann J Lutzky L Camacho G Parmiani G Tosti JM Kirkwood A Hoos L Yuh R Gupta PK Srivastava C-100-21 Study Group 2008 Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group J Clin Oncol 26 6 955 962 1:CAS:528:DC%2BD1cXjtFelt7s%3D 10.1200/JCO.2007.11.9941 18281670 Erratum in: J Clin Oncol 26(22): 3819 (Pubitemid 351398090)
39. MF Tsan B Gao 2004 Cytokine function of heat shock proteins Am J Physiol Cell Physiol 286 4 C739 C744 1:CAS:528:DC%2BD2cXjtlagsbc%3D 10.1152/ajpcell. 00364.2003 15001423
40. + T cells in vivo Proc Natl Acad Sci USA 91 8 3077 3081 1:CAS:528:DyaK2cXivFKls7o%3D 10.1073/pnas.91.8.3077 7909157 (Pubitemid 24130178)
41. RP Wallin A Lundqvist SH More A von Bonin R Kiessling HG Ljunggren 2002 Heat-shock proteins as activators of the innate immune system Trends Immunol 23 3 130 135 1:CAS:528:DC%2BD38XhsFahtrc%3D 10.1016/S1471-4906(01)02168-8 11864840 (Pubitemid 34178294)
42. HH Wang CY Mao LS Teng J Cao 2006 Recent advances in heat shock protein-based cancer vaccines Hepatobiliary Pancreat Dis Int 5 1 22 27 1:CAS:528:DC%2BD28XisF2rtb4%3D 16481277
43. SP Yedavelli L Guo ME Daou PK Srivastava A Mittelman RK Tiwari 1999 Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model Int J Mol Med 4 3 243 248 1:CAS:528:DyaK1MXls1WhsbY%3D 10425272